CT-based radiomics for prediction of histologic subtype and metastatic disease in primary malignant lung neoplasms.

Journal: International journal of computer assisted radiology and surgery
Published Date: Nov 13, 2019

Abstract

PURPOSE: As some of the most important factors for treatment decision of lung cancer (which is the deadliest neoplasm) are staging and histology, this work aimed to associate quantitative contrast-enhanced computed tomography (CT) features from malignant lung tumors with distant and nodal metastases (according to clinical TNM staging) and histopathology (according to biopsy and surgical resection) using radiomics assessment.

Authors

  • José Raniery Ferreira-Junior
    São Carlos School of Engineering, University of São Paulo, Av. Trabalhador São-Carlense, 400, São Carlos, SP, 13566-590, Brazil. jose.raniery@usp.br.
  • Marcel Koenigkam-Santos
    Ribeirão Preto Medical School, University of São Paulo, Av. dos Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
  • Ariane Priscilla Magalhães Tenório
    Ribeirão Preto Medical School, University of São Paulo, Av. dos Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
  • Matheus Calil Faleiros
    São Carlos School of Engineering, University of São Paulo, Av. Trabalhador São-Carlense, 400, São Carlos, SP, 13566-590, Brazil.
  • Federico Enrique Garcia Cipriano
    Ribeirão Preto Medical School, University of São Paulo, Av. dos Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
  • Alexandre Todorovic Fabro
    Ribeirão Preto Medical School, University of São Paulo, Av. dos Bandeirantes, 3900, Ribeirão Preto, SP, 14049-900, Brazil.
  • Janne Näppi
    Massachusetts General Hospital, Harvard Medical School, 25 New Chardon St, Boston, MA, 02114, USA.
  • Hiroyuki Yoshida
    From the 3D Imaging Research Lab, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, 25 New Chardon St, Suite 400C, Boston, MA 02114 (R.T., J.J.N., N.K., T.H., H.Y.); Department of Information Science and Technology, National Institute of Technology, Oshima College, Yamaguchi, Japan (R.T.); Department of Medical Physics and Engineering, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan (J.O.); Department of Medical Physics, University of Applied Sciences Giessen, Giessen, Germany (N.K.); Department of Radiology, Seoul National University Hospital, Seoul, Republic of Korea (S.H.K.); Department of Surgical Sciences, University of Torino, Turin, Italy (D.R.); and Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-Istituto di Ricovero e Cura a Carattere Scientifico (FPO-IRCCS), Candiolo, Turin, Italy (D.R.).
  • Paulo Mazzoncini de Azevedo-Marques
    Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil.

Keywords

External Resources

Popular Topics
Recent Journals